K. Wyatt Engwall, Director at THERAGENICS CORP (TGX), bought 26,200 shares at $1.19 ($31K) on 2010-06-01, disclosed to the SEC on 2010-06-03.
Open-market purchase of $31k TGX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TGX | BUY | 2008-11-07 | $30K | — | Filing → |
| TGX | BUY | 2008-08-28 | $70K | — | Filing → |